Takeda Pharmaceuticals , the manufacturer, has faced thousands of lawsuits from patients alleging they were not properly warned about the risk of bladder cancer. Actos Recall in the U.S. | Girard Gibbs LLP
: Following a 2011 French study linking the drug to bladder cancer, medical authorities in France and Germany suspended or banned the use of Actos. ACTOS RECALL
: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%. ACTOS RECALL
While there have been significant legal and international developments, it is important to clarify that . ACTOS RECALL